Certain groups of people are likely to benefit from the fourth dose of a COVID-19 vaccine, Moderna President Stephen Hoge said on Monday. The elderly and the immunocompromised are recommended to receive a fourth shot of the vaccine, he said. “For those who are immune-compromised, those who are older adults, over the age of 50…
Moderna President: We ‘Strongly Recommend’ 4th Vaccine Dose For Certain Groups
Chart Wars: Between Moderna and Novavax, Which COVID Stock Will Soar Higher?
March 10, 2022
admin
AMERICABusiness & EconomyBusinesses in COVID-19CCP VirusCompanieseconomyMarketsModernaNovavaxstockstocksVaccineVaccines & SafetyWorld
0 Comment
Moderna, Inc. and Novavax, Inc. were trading up over 10 percent and 8 percent, respectively, at one point on Wednesday, boosted by the S&P 500’s almost 2.6 percent intraday gain. The pharmaceutical stocks have been heavily beaten down over the past many months, with Moderna declining over 70 percent from its Aug. 10, 2021 all-time high…
Australian University to Collaborate with Moderna for mRNA Vaccine Research
March 10, 2022
admin
AustraliaCCP VirusCOVID-19 vaccinecslMark WalkerModernamRNA technologyNikolai PetrovskyScienceScience NewsUniversity of QueenslandVaccines & SafetyWorld
0 Comment
The University of Queensland announced its collaboration with Moderna to use mRNA research for vaccine development of diseases that pose risks of causing future pandemics. The university previously collaborated with CSL—a major biotechnology firm now responsible for the manufacturing of the AstraZeneca vaccine in Australia—on producing a COVID-19 vaccine. The deal was called off, however,…
Moderna Hijacked Technology for COVID-19 Vaccine, Lawsuit Alleges
Two biotechnology companies filed a lawsuit against Moderna this week and alleged the vaccine manufacturer infringed on patented technology in the development of its commonly used COVID-19 shot. Arbutus Biopharma and Genevant Sciences, the companies, claim in a civil lawsuit that Moderna used “breakthrough technology Arbutus had already created and patented” to create the COVID-19…
Moderna Makes Case for 4th COVID-19 Vaccine Booster This Year, Shares Jump
Moderna Inc. executives said on Thursday they believe a fourth COVID-19 vaccine shot will be needed late this year due to waning protection from earlier doses, which could push up sales in the second half of 2022. Chief Executive Stephane Bancel stressed that the company’s current sales projections for its Spikevax COVID-19 shot—$19 billion in…
Australia Approves Moderna Vaccine For 6 to 11s
February 23, 2022
admin
AustraliaCCP VirusCOVAX-19Greg Huntjohn skerrittModernaModerna COVID-19 vaccineNovavaxVaccines & SafetyWorld
0 Comment
The Moderna COVID-19 vaccine has now been approved as the primary course for children aged 6 to 11 in Australia. Speaking at the press conference on Feb. 23, Health Minister Greg Hunt said Moderna gives “more choice and flexibility” for parents along with the Pfizer vaccine which is approved for children aged 5 and older….
Moderna Begins Late-Stage Study of RSV Vaccine Using mRNA Technology
February 23, 2022
admin
AMERICABusiness & EconomyBusinesses in COVID-19CCP VirusCompanieseconomyModernamRNArespiratory syncytial virusstudyUSUS NewsVaccineVaccines & Safety
0 Comment
Moderna Inc. said on Tuesday it had begun a late-stage study of its vaccine for Respiratory Syncytial Virus (RSV) based on the same technology used to develop its COVID-19 shots. The only approved product using messenger RNA (mRNA)is COVID-19 vaccine, but Moderna and rival Pfizer are rushing to tap the potential of the technology to…
‘Worst Experience of My Life’: Early Vaccine Adopters Suffer Injuries, Struggle to Get Proper Care
Dr. Danice Hertz remembers vividly the day she got a COVID-19 vaccine. Hertz, a retired gastroenterologist, received Pfizer’s shot on Dec. 23, 2020, less than two weeks after U.S. regulators granted it emergency use authorization. Thirty minutes went by before an adverse reaction started. “My face started burning and tingling and my eyes got blurry,”…
Moderna CEO Says Last Stages of COVID-19 Pandemic Are in Sight
Moderna chief executive officer Stephane Bancel has said he feels it’s “a reasonable scenario” to assume that the last stages of the COVID-19 pandemic are in sight. In an interview with CNBC’s “Squawk Box Asia” on Wednesday, the CEO of the American pharmaceutical and biotechnology company reiterated comments made by other health professionals, including World Health Organization (WHO) Regional…
Moderna, AstraZeneca Partnering To Develop an ‘mRNA Therapeutic’ For Heart Disease
Drugmakers Moderna and AstraZeneca are partnering up to develop a “mRNA therapeutic” to treat life-threatening cardiovascular disease such as heart failure. “We are collaborating with @AstraZeneca on an mRNA therapeutic (AZD8601) that encodes for VEGF-A to promote recovery of cardiac function through tissue regeneration,” Moderna said in a Twitter post Thursday. The biotechnology company included…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`